According to the study of Chen, IncRNA NEAT1 induces sorafenib resistance of HCC patients through repressing miR-335 expression and activation of c-Met-Akt signaling pathway (Shao et al., 2015) and the combination of HGF and c-Met inhibitors and sorefenib could improve the efficacy of the first line systemic treatment ( In conclusion, although the tivantinib phase III trial failed and the reason is not clear, the role of c-Met inhibitors in treating HCC can not be denied
Anti-Aging Properties: Reduces oxidative damage and helps slow down signs of aging by supporting skin elasticity and cell regeneration
Niu, K., Bao, T., Gao, L., Ru, M., Li, Y., Jiang, L., Ye, C., Wang, S., & Wu, X
See how that works
Crystalline form B is also characterised by a DSC pattern, obtained with a heating rate of 10.00 C./min, having an endothermic decomposition peak between 180 C
consult the drug's package insert to verify compatibility before use